(Q44551857)

English

Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy

scientific article published in August 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

nephrotic syndrome

1 reference

based on heuristic

inferred from title

9

object named as

Yuji Matsuzawa

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Takeshi Arai

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Shizuya Yamashita

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Mitsukazu Yamane

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Noriko Manabe

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Toshiyuki Matsuzaki

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Kazuo Kiriyama

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yoshio Kanayama

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Seiichi Himeno

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

169

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

293-299

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Renal lipidoses: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type 3 hyperlipoproteinemia)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Lipoprotein glomerulopathy: first report in a Chinese male

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Recurrence of lipoprotein glomerulopathy after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Lipoprotein glomerulopathy with a new apolipoprotein E phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Nondenaturing polyacrylamide gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Virus-mediated transduction of apolipoprotein E (ApoE)-sendai develops lipoprotein glomerulopathy in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Lipoprotein glomerulopathy and its pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Lipolytic enzymes and plasma lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Effect of bezafibrate treatment on the altered lipoprotein profiles in hypertriglyceridemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900194-1

7 January 2021

Identifiers

10.1016/S0021-9150(03)00194-1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44551857&oldid=2027698649"